| 臺大學術典藏 |
2020-03-26T06:54:33Z |
Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer
|
ANG YUAN; Yu C.-J.; Chen W.-J.; Lin F.-Y.; Kuo S.-H.; Luh K.-T.; Yang P.-C.; Ang Yuan;Yu C.-J.;Chen W.-J.;Lin F.-Y.;Kuo S.-H.;Luh K.-T.;Yang P.-C. |
| 臺大學術典藏 |
2020-03-26T06:54:33Z |
Quantification of VEGF mRNA expression in non-small cell lung cancer using a real-time quantitative reverse transcription-PCR assay and a comparison with quantitative competitive reverse transcription-PCR
|
Ang Yuan;Yu C.-J.;Luh K.-T.;Chen W.-J.;Lin F.-Y.;Kuo S.-H.;Yang P.-C.; ANG YUAN; Yu C.-J.; Luh K.-T.; Chen W.-J.; Lin F.-Y.; Kuo S.-H.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-26T06:54:33Z |
Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer
|
Lee Y.-C.; Lin F.-Y.; Kwen-Tay, Luh, Yang P.-C.; Chen W.-J.; Kuo S.-H.; Yu C.-J.; ANG YUAN; Ang Yuan;Yu C.-J.;Kuo S.-H.;Chen W.-J.;Lin F.-Y.;Kwen-Tay, Luh, Yang P.-C.;Lee Y.-C. |
| 臺大學術典藏 |
2020-03-26T06:54:27Z |
Transcription repressor Slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma
|
Yang P.-C.; ANG YUAN; Yu C.-J.; Lin S.-B.; Liou G.-Y.; Lee M.-L.; Chen J.J.W.; Hong T.-M.; Yang S.-C.; Su J.-L.; Lee Y.-C.; Chang Y.-L.; Chang T.-H.; Tsai M.-F.; Shih J.-Y.; Shih J.-Y.;Tsai M.-F.;Chang T.-H.;Chang Y.-L.;Ang Yuan;Yu C.-J.;Lin S.-B.;Liou G.-Y.;Lee M.-L.;Chen J.J.W.;Hong T.-M.;Yang S.-C.;Su J.-L.;Lee Y.-C.;Yang P.-C. |
| 臺大學術典藏 |
2020-03-26T06:54:22Z |
Signal transducer and activator of transcription 3 as molecular therapy for non-small-cell lung cancer
|
Wang C.-Y.; Chao T.-T.; Tai W.-T.; Chang F.-Y.; Su W.-P.; Chen Y.-L.; Chen P.-T.; Weng C.-Y.; ANG YUAN; Shiau C.-W.; Yu C.-J.; Chen K.-F. |
| 臺大學術典藏 |
2020-03-25T08:48:27Z |
Invasive Infections of Aggregatibacter (Actinobacillus) Actinomycetemcomitans
|
Lin P.-Y.; Lee L.-N.; Yu C.-J.; Yang P.-C.; Hsueh P.-R.; Ho Y.-K.; Wang C.-Y.;Hui-Chih Wang;Li J.-M.;Wang J.-Y.;Yang K.-C.;Ho Y.-K.;Lin P.-Y.;Lee L.-N.;Yu C.-J.;Yang P.-C.;Hsueh P.-R.; Wang C.-Y.; HUI-CHIH WANG; Li J.-M.; Wang J.-Y.; Yang K.-C. |
| 臺大學術典藏 |
2020-03-16T03:26:59Z |
International joint ventures: Theoretical considerations
|
Tang M.-J.; Yu C.J |
| 臺大學術典藏 |
2020-03-07T06:57:19Z |
Sonographic imaging of the trachea
|
Shih J.-Y.;Lee L.-N.;Wu H.-D.;Yu C.-J.;Wang H.-C.;Yih-Leong Chang;Yang P.-C.; Shih J.-Y.; Lee L.-N.; Wu H.-D.; Yu C.-J.; Wang H.-C.; YIH-LEONG CHANG; Yang P.-C. |
| 臺大學術典藏 |
2020-03-07T06:57:11Z |
US-guided transthoracic cutting biopsy for peripheral thoracic lesions less than 3 cm in diameter
|
Liao W.-Y.;Chen M.-Z.;Yih-Leong Chang;Wu H.-D.;Yu C.-J.;Kuo P.-H.;Yang P.-C.; Liao W.-Y.; Chen M.-Z.; YIH-LEONG CHANG; Wu H.-D.; Yu C.-J.; Kuo P.-H.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-07T06:57:11Z |
Disseminated cytomegalovirus disease in a patient with systemic lupus erythematosus not undergoing immunosuppressive therapy
|
Yu C.-J.; YIH-LEONG CHANG; Yang P.-C.; Ku S.-C.; Yang P.-C.;YIH-LEONG CHANG;Yu C.-J.;Ku S.-C. |
| 臺大學術典藏 |
2020-03-07T06:57:07Z |
Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells
|
Shih J.-Y.; Yang S.-C.; Hong T.-M.; Yuan A.; Chen J.J.W.; Yu C.-J.; YIH-LEONG CHANG; Lee Y.-C.; Peck K.; Wu C.-W.; Yang P.-C.; Shih J.-Y.;Yang S.-C.;Hong T.-M.;Yuan A.;Chen J.J.W.;Yu C.-J.;Yih-Leong Chang;Lee Y.-C.;Peck K.;Wu C.-W.;Yang P.-C. |
| 臺大學術典藏 |
2020-03-07T06:57:04Z |
Diffuse alveolar damage associated with ticlopidine use: A case report
|
Oon P.-C.;Jerng J.-S.;Kao H.-L.;Yih-Leong Chang;Yu C.-J.;Yang P.-C.; Oon P.-C.; Jerng J.-S.; Kao H.-L.; YIH-LEONG CHANG; Yu C.-J.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-07T06:56:56Z |
Acquired gefitinib-resistant mutation of EGFR in a chemonaive lung adenocarcinoma harboring gefitinib-sensitive mutation L858R
|
Gow C.-H.;Shih J.-Y.;Yih-Leong Chang;Yu C.-J.; Gow C.-H.; Shih J.-Y.; YIH-LEONG CHANG; Yu C.-J. |
| 臺大學術典藏 |
2020-03-07T06:56:55Z |
Transcription repressor Slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma
|
Yuan A.; Yu C.-J.; Lin S.-B.; Liou G.-Y.; Lee M.-L.; Chen J.J.W.; Hong T.-M.; Yang S.-C.; Su J.-L.; Lee Y.-C.; Yang P.-C.; Shih J.-Y.;Tsai M.-F.;Chang T.-H.;Yih-Leong Chang;Yuan A.;Yu C.-J.;Lin S.-B.;Liou G.-Y.;Lee M.-L.;Chen J.J.W.;Hong T.-M.;Yang S.-C.;Su J.-L.;Lee Y.-C.;Yang P.-C.; Shih J.-Y.; Tsai M.-F.; Chang T.-H.; YIH-LEONG CHANG |
| 臺大學術典藏 |
2020-03-07T06:56:54Z |
Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer
|
Shih J.-Y.;Gow C.-H.;Yu C.-J.;Yang C.-H.;Yih-Leong Chang;Tsai M.-F.;Hsu Y.-C.;Chen K.-Y.;Su W.-P.;Yang P.-C.; Shih J.-Y.; Gow C.-H.; Yu C.-J.; Yang C.-H.; YIH-LEONG CHANG; Tsai M.-F.; Hsu Y.-C.; Chen K.-Y.; Su W.-P.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-07T06:56:49Z |
Identification of trophinin as an enhancer for cell invasion and a prognostic factor for early stage lung cancer
|
Lai J.-M.; YIH-LEONG CHANG; Lee Y.-C.; Yu C.-J.; Huang C.-Y.F.; Yang P.-C.; Lee Y.-C.G.; Chen K.-Y.; Yang P.-C.;Huang C.-Y.F.;Yu C.-J.;Lee Y.-C.;YIH-LEONG CHANG;Lai J.-M.;Lee Y.-C.G.;Chen K.-Y. |
| 臺大學術典藏 |
2020-03-07T06:56:47Z |
Lung abscess due to Clostridium baratii infection in a patient with invasive pulmonary aspergillosis
|
Shu C.-C.;Yao M.;Hung C.-C.;Ku S.-C.;Yu C.-J.;Yih-Leong Chang; Shu C.-C.; Yao M.; Hung C.-C.; Ku S.-C.; Yu C.-J.; YIH-LEONG CHANG |
| 臺大學術典藏 |
2020-03-07T06:56:47Z |
Radiotherapy in lung adenocarcinoma with brain metastases: Effects of activating epidermal growth factor receptor mutations on clinical response
|
Gow C.-H.;Chien C.-R.;Yih-Leong Chang;Chiu Y.-H.;Kuo S.-H.;Shih J.-Y.;Chang Y.-C.;Yu C.-J.;Yang C.-H.;Yang P.-C.; Gow C.-H.; Chien C.-R.; YIH-LEONG CHANG; Chiu Y.-H.; Kuo S.-H.; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Yang C.-H.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-07T06:56:45Z |
Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma
|
Wu S.-G.; Gow C.-H.; Yu C.-J.; YIH-LEONG CHANG; Yang C.-H.; Hsu Y.-C.; Shih J.-Y.; Lee Y.-C.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-07T06:56:45Z |
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response
|
Wu J.-Y.;Wu S.-G.;Yang C.-H.;Gow C.-H.;Yih-Leong Chang;Yu C.-J.;Shin J.-Y.;Yang P.-C.; Wu J.-Y.; Wu S.-G.; Yang C.-H.; Gow C.-H.; YIH-LEONG CHANG; Yu C.-J.; Shin J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-07T06:56:44Z |
Small-cell lung carcinoma presenting with otalgia and hearing impairment
|
Yu C.-J.; Lee L.-N.; Kuo Y.-W.; Chen K.-Y.; YIH-LEONG CHANG |
| 臺大學術典藏 |
2020-03-07T06:56:43Z |
Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer
|
Gow C.-H.; YIH-LEONG CHANG; Hsu Y.-C.; Tsai M.-F.; Wu C.-T.; Yu C.-J.; Yang C.-H.; Lee Y.-C.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-07T06:56:39Z |
Epidermal growth factor receptor mutations in small cell lung cancer: A brief report
|
Shiao T.-H. ;Yih-Leong Chang ;Yu C.-J. ;Chang Y.-C. ;Hsu Y.-C. ;Chang S.-H. ;Shih J.-Y. ;Yang P.-C.; Shiao T.-H.; YIH-LEONG CHANG; Yu C.-J.; Chang Y.-C.; Hsu Y.-C.; Chang S.-H.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-07T06:56:38Z |
Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations
|
Wu S.-G. ;Yang C.-H. ;Yu C.-J. ;Lee J.-H. ;Hsu Y.-C. ;Yih-Leong Chang ;Shih J.-Y. ;Yang P.-C.; Wu S.-G.; Yang C.-H.; Yu C.-J.; Lee J.-H.; Hsu Y.-C.; YIH-LEONG CHANG; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-07T06:56:38Z |
Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction
|
Wu S.-G. ;Yih-Leong Chang ;Lin J.-W. ;Wu C.-T. ;Chen H.-Y. ;Tsai M.-F. ;Lee Y.-C. ;Yu C.-J. ;Shih J.-Y.; Wu S.-G.; YIH-LEONG CHANG; Lin J.-W.; Wu C.-T.; Chen H.-Y.; Tsai M.-F.; Lee Y.-C.; Yu C.-J.; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-07T06:56:37Z |
Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: The association with treatment efficacy of pemetrexed
|
Chen C.-Y. ;Yih-Leong Chang ;Shih J.-Y. ;Lin J.-W. ;Chen K.-Y. ;Yang C.-H. ;Yu C.-J. ;Yang P.-C.; Chen C.-Y.; YIH-LEONG CHANG; Shih J.-Y.; Lin J.-W.; Chen K.-Y.; Yang C.-H.; Yu C.-J.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-07T06:56:37Z |
Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations
|
Yuan S.; Yu S.-L.; Chen H.-Y.; Hsu Y.-C.; Su K.-Y.; Chen H.-W.; Chen C.-Y.; Yu C.-J.; Shih J.-Y.; YIH-LEONG CHANG; Cheng C.-L.; Hsu C.-P.; Hsia J.-Y.; Lin C.-Y.; Wu G.; Liu C.-H.; Wang C.-D.; Yang K.-C.; Chen Y.-W.; Lai Y.-L.; Hsu C.-C.; Lin T.-C.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Chen J.J.W.; Chang G.-C.; Li K.-C.; Yang P.-C.; Yuan S. ;Yu S.-L. ;Chen H.-Y. ;Hsu Y.-C. ;Su K.-Y. ;Chen H.-W. ;Chen C.-Y. ;Yu C.-J. ;Shih J.-Y. ;Yih-Leong Chang ;Cheng C.-L. ;Hsu C.-P. ;Hsia J.-Y. ;Lin C.-Y. ;Wu G. ;Liu C.-H. ;Wang C.-D. ;Yang K.-C. ;Chen Y.-W. ;Lai Y.-L. ;Hsu C.-C. ;Lin T.-C. ;Yang T.-Y. ;Chen K.-C. ;Hsu K.-H. ;Chen J.J.W. ;Chang G.-C. ;Li K.-C. ;Yang P.-C. |
| 臺大學術典藏 |
2020-03-07T06:56:35Z |
Clinical significance of thyroid transcription factor-1 in advanced lung adenocarcinoma under epidermal growth factor receptor tyrosine kinase inhibitor treatment
|
Chung K.-P.; Huang Y.-T.; YIH-LEONG CHANG; Yu C.-J.; Yang C.-H.; Chang Y.-C.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-07T06:56:35Z |
EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR
|
Wu S.-G.;Kuo Y.-W.;Yih-Leong Chang;Shih J.-Y.;Chen Y.-H.;Tsai M.-F.;Yu C.-J.;Yang C.-H.;Yang P.-C.; Wu S.-G.; Kuo Y.-W.; YIH-LEONG CHANG; Shih J.-Y.; Chen Y.-H.; Tsai M.-F.; Yu C.-J.; Yang C.-H.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-07T06:56:35Z |
Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma
|
Tsai T.-H.; Wu S.-G.; YIH-LEONG CHANG; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; Yu C.-J.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-07T06:56:34Z |
RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer
|
Tsai T.-H.; Su K.-Y.; Wu S.-G.; YIH-LEONG CHANG; Luo S.-C.; Jane I.-S.; Yu C.-J.; Yue S.-L.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-07T06:56:33Z |
Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis
|
Wu S.-G.; Hu F.-C.; YIH-LEONG CHANG; Lee Y.-C.; Yu C.-J.; Chang Y.-C.; Wu J.-Y.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-07T06:56:27Z |
Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations
|
Chen Y.-F.;Hsieh M.-S.;Wu S.-G.;Yih-Leong Chang;Shih J.-Y.;Liu Y.-N.;Tsai M.-F.;Tsai T.-H.;Yu C.-J.;Yang J.C.-H.;Yang P.-C.; YIH-LEONG CHANG; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; Tsai T.-H.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.; Chen Y.-F.; Hsieh M.-S.; Wu S.-G. |
| 臺大學術典藏 |
2020-03-07T06:56:19Z |
Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations
|
Chen Y.-F.;Hsieh M.-S.;Wu S.-G.;Yih-Leong Chang;Yu C.-J.;Yang J.C.-H.;Yang P.-C.;Shih J.-Y.; Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; YIH-LEONG CHANG; Yu C.-J.; Yang J.C.-H.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-07T06:56:18Z |
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients
|
Wu S-G.; Liu Y.-N.; Tsai M.-F.; YIH-LEONG CHANG; Yu C.-J.; Yang P.-C.; Yang J.C.-H.; Wen Y.-F.; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-07T06:56:16Z |
The role of PIK3CA mutations among lung adenocarcinoma patients with primary and acquired resistance to EGFR tyrosine kinase inhibition
|
Wu S.-G.; YIH-LEONG CHANG; Yu C.-J.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-07T06:56:13Z |
Astrocyte-elevated gene-1 confers resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase expression
|
Chen C.-Y.;Chen Y.-Y.;Chen J.J.W.;Chen K.-Y.;Ho C.-C.;Shih J.-Y.;Yih-Leong Chang;Yu C.-J.;Yang P.-C.; Chen C.-Y.; Chen Y.-Y.; Chen J.J.W.; Chen K.-Y.; Ho C.-C.; Shih J.-Y.; YIH-LEONG CHANG; Yu C.-J.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-07T06:56:12Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; YIH-LEONG CHANG; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H.; Lin C.-C.;Shih J.-Y.;Yu C.-J.;Ho C.-C.;Liao W.-Y.;Lee J.-H.;Tsai T.-H.;Su K.-Y.;Hsieh M.-S.;Yih-Leong Chang;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H. |
| 臺大學術典藏 |
2020-03-07T06:56:12Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Liao W.-Y.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Yih-Leong Chang;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; YIH-LEONG CHANG; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2020-03-07T06:56:11Z |
IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer
|
Tsai M.-F.; Liu Y.-N.; Hsu C.-L.; YIH-LEONG CHANG; Yu C.-J.; Shih J.-Y.; Wu S.-G.;Chang T.-H.;Tsai M.-F.;Liu Y.-N.;Hsu C.-L.;Yih-Leong Chang;Yu C.-J.;Shih J.-Y.; Wu S.-G.; Chang T.-H. |
| 臺大學術典藏 |
2020-03-07T06:56:09Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Yih-Leong Chang;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; YIH-LEONG CHANG; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-03-06T05:26:58Z |
Sonographic imaging of the trachea
|
Shih J.-Y.; Lee L.-N.; Wu H.-D.; Yu C.-J.; Wang H.-C.; YIH-LEONG CHANG; Yang P.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:52Z |
US-guided transthoracic cutting biopsy for peripheral thoracic lesions less than 3 cm in diameter
|
Liao W.-Y.; Chen M.-Z.; YIH-LEONG CHANG; Wu H.-D.; Yu C.-J.; Kuo P.-H.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:52Z |
Disseminated cytomegalovirus disease in a patient with systemic lupus erythematosus not undergoing immunosuppressive therapy
|
Ku S.-C.; Yu C.-J.; YIH-LEONG CHANG; Yang P.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:49Z |
Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells
|
Shih J.-Y.; Yang S.-C.; Hong T.-M.; Yuan A.; Chen J.J.W.; Yu C.-J.; YIH-LEONG CHANG; Lee Y.-C.; Peck K.; Wu C.-W.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:46Z |
Patient mortality of active pulmonary tuberculosis requiring mechanical ventilation
|
Lee P.L.; Jerng J.S.; YIH-LEONG CHANG; Chen C.F.; Hsueh P.R.; Yu C.J.; Yang P.C.; Luh K.T. |
| 臺大學術典藏 |
2020-03-06T05:26:46Z |
Diffuse alveolar damage associated with ticlopidine use: A case report
|
Oon P.-C.; Jerng J.-S.; Kao H.-L.; YIH-LEONG CHANG; Yu C.-J.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:40Z |
Transcription repressor Slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma
|
Yang P.-C.; Lee Y.-C.; Su J.-L.; Yang S.-C.; Hong T.-M.; Chen J.J.W.; Lee M.-L.; Liou G.-Y.; Lin S.-B.; Shih J.-Y.; Tsai M.-F.; Chang T.-H.; YIH-LEONG CHANG; Yuan A.; Yu C.-J. |
| 臺大學術典藏 |
2020-03-06T05:26:40Z |
Acquired gefitinib-resistant mutation of EGFR in a chemonaive lung adenocarcinoma harboring gefitinib-sensitive mutation L858R
|
Gow C.-H.; Shih J.-Y.; YIH-LEONG CHANG; Yu C.-J. |
| 臺大學術典藏 |
2020-03-06T05:26:38Z |
Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer
|
Shih J.-Y.; Gow C.-H.; Yu C.-J.; Yang C.-H.; YIH-LEONG CHANG; Tsai M.-F.; Hsu Y.-C.; Chen K.-Y.; Su W.-P.; Yang P.-C. |
